Physician profile
Keith A Heslinger
NPI 1275540718
$7,776.19
in general payments reported to CMS, 2019-2025
24 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,576 · 2020: $20.00 · 2021: $526 · 2022: $1,048 · 2023: $107 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $106.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,992.79 | 2019-2025 | |
| Myovant Sciences INC. | $450.84 | 2021-2022 | |
| Abbvie INC. | $370.78 | 2019-2023 | |
| Caldera Medical, INC | $146.17 | 2021-2022 | |
| Aspira Women'S Health INC | $121.59 | 2022 | |
| Pfizer INC. | $110.29 | 2019-2022 | |
| Dysis Medical, INC. | $95.46 | 2021-2022 | |
| Hologic Sales and Service, LLC | $81.53 | 2019-2023 | Omni Hysteroscope, Acessa Provu System |
| Daiichi Sankyo INC. | $50.03 | 2022 | |
| Ethicon US, LLC | $36.44 | 2022 | |
| Evofem Biosciences, INC. | $34.81 | 2022 | |
| Astellas Pharma US INC | $33.94 | 2021 | |
| Novo Nordisk INC | $33.09 | 2022 | |
| Organon LLC | $30.87 | 2021-2022 | |
| Allergan, INC. | $25.72 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $23.45 | 2023 | Myfembree |
| Becton, Dickinson and Company | $22.24 | 2021 | |
| Coloplast Corp | $20.65 | 2022 | |
| Coopersurgical, INC. | $19.57 | 2022 | |
| Therapeuticsmd, INC. | $17.29 | 2021 | |
| Exeltis, USA INC. | $16.49 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.01 | 2021 | |
| Ascend Therapeutics US, LLC | $14.25 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Heslinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.